IRIS
metadata only
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60#1127099
- Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)#875861
- The Clinical Study on the Treatment of SSc With UTAA91 Injection.#915628
- Improving Standards of Care and Translational Research in Spinal Muscular Atrophy (SMA)#1087403
- Treatment of Early Systemic Sclerosis by Bosentan#831649
Record · ID 284485
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive